Efficacy and Safety Study of Niraparib in Melanoma With Genetic Homologous Recombination (HR) Mutation
Clinical trial NCT03925350 · UNKNOWN
Trial details
- NCT number
- NCT03925350
- Sponsor
- California Pacific Medical Center Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-20
- Primary completion
- 2022-02-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.